Skip to Content
Merck
CN

CLL1223

Safe Harbor Landing Pad Cell Line THP-1 Monocytes

human male peripheral blood (Source Disease: Acute monocytic leukemia)

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
41106514
NACRES:
NB.01
Biological source:
human male peripheral blood (Source Disease: Acute monocytic leukemia)
Growth mode:
Suspension
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

Safe Harbor Landing Pad Cell Line THP-1 Monocytes,

biological source

human male peripheral blood (Source Disease: Acute monocytic leukemia)

Quality Segment

form

frozen liquid (Vial of Frozen Cells)

growth mode

Suspension

technique(s)

cell culture | mammalian: suitable

shipped in

dry ice

storage temp.

−196°C

General description

The STR profile of this cell line matches that of its parental cell line ATCC®Catalog No. TIB-202. THP-1 are a human monocyte cell line isolated from the peripheral blood of a male infant with acute monocytic leukemia. The cells are phagocytic and lack surface and cytoplasmic immunoglobulins. Differentiation can be induced with TPA.

Application

This product is a human THP-1 monocyte cell line in which a landing pad cassette has been integrated into the AAVS1 safe harbor locus using CompoZr® Zinc Finger Nuclease technology. The mKATE2 fluorescence gene was integrated following the EF1a promoter and flanked by unique Cre-lox sites. The design of this landing pad cassette allows for easy, fast, and affordable genetic modification using Cre recombinase. mKATE2 can easily be exchanged for a payload of the user′s choice using Cre recombinase and a targeting vector with appropriate lox sites. Cells can then be sorted via fluorescence-activated cell sorting (FACS) for loss of mKATE2 expression as a surrogate for successful integration of the targeting vector. Approximately 7-10 days are required for loss of the mKATE2 signal in successfully targeted cells. See technical bulletin for detailed protocols.

Biochem/physiol Actions

These cells were derived from the peripheral blood of a 1-year old male with acute monocytic leukemia. These cells have Fc and C3b receptors and lack surface and cytoplasmic immunoglobulins. They stain positive for α-napthhyl butyrate esterase, produce lysozymes, and are phagocytic (both latex beads and sensitized erythrocytes). They can restore the response of purified T lymphocytes to Concanavalin A, show increased CO2 production on phagocytosis, and can be differentiated into macrophage-like cells using, for example, DMSO.

Features and Benefits

These cells contain the mKATE2 fluorescence gene flanked by unique Cre-lox sites inserted in the AAVS1 safe harbor gene. These THP-1 cells are grown in suspension with a doubling time of approximately 24 hours.

Analysis Note

Tested for Mycoplasma, bacterial and fungal content, post-freeze viability, short terminal repeat (STR) analysis for cell line identification.

Legal Information

CompoZr is a registered trademark of Merck KGaA, Darmstadt, Germany
ATCC is a registered trademark of American Type Culture Collection


pictograms

Corrosion

signalword

Warning

hcodes

Hazard Classifications

Met. Corr. 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Storage Class

10 - Combustible liquids



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library